ECS — ECS Botanics Holdings Share Price
- AU$15.55m
- AU$17.84m
- AU$20.45m
- 44
- 89
- 13
- 48
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.59 | ||
Price to Tang. Book | 0.67 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.84 | ||
EV to EBITDA | 202.08 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -4.57% | ||
Return on Equity | -5.27% | ||
Operating Margin | -6.95% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | AU$m | 0.92 | 1.38 | 5.61 | 15.67 | 20.45 | n/a | n/a | 277.85% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
ECS Botanics Holdings Ltd is an Australia-based medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The Company utilizes progressive and cultivation methodologies to produce medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. The Company operates through two segments: ECS Botanics Pty Ltd (Botanics) and ECS Botanics MC Pty Ltd and Flowerday Farms Pty Ltd. Botanics is engaged in the sale of food and wellness products. ECS Botanics MC Pty Ltd and Flowerday Farms Pty Ltd are engaged in the sale of medicinal cannabis plant related products. It specializes in cultivating cannabis, which after drying and curing, is supplied as a trimmed flower for inhalation, or extracted into resin for further formulation or manufacturing. It cultivates a range of strains for extraction and inhalation. It also formulates a range of off the shelf and bespoke formulations to suite needs.
Directors
- Robert Pickering CTO
- Damian Woods OTH
- Mauro Piccini SEC
- Alexander Keach DRC
- Jeremy King DRC (43)
- David McCredie DRC
- Nan - Maree Schoerie DRC
- Michael Nitsche NED
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 20th, 1970
- Public Since
- April 11th, 1983
- No. of Shareholders
- 4,346
- No. of Employees
- 220
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS
- Shares in Issue
- 1,296,049,567

- Address
- Se 2 L 1, 1 Altona St, PERTH, 6005
- Web
- https://ecs-botanics.com/
- Phone
- +61 865591792
- Auditors
- William Buck Audit (Vic) Pty Ltd
Upcoming Events for ECS
Full Year 2025 ECS Botanics Holdings Ltd Earnings Release
Similar to ECS
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
Careteq
Australian Stock Exchange - SEATS
FAQ
As of Today at 20:22 UTC, shares in ECS Botanics Holdings are trading at AU$0.01. This share price information is delayed by 15 minutes.
Shares in ECS Botanics Holdings last closed at AU$0.01 and the price had moved by -45.45% over the past 365 days. In terms of relative price strength the ECS Botanics Holdings share price has underperformed the ASX All Ordinaries Index by -47.43% over the past year.
There is no consensus recommendation for this security.
Find out moreECS Botanics Holdings does not currently pay a dividend.
ECS Botanics Holdings does not currently pay a dividend.
ECS Botanics Holdings does not currently pay a dividend.
To buy shares in ECS Botanics Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.01, shares in ECS Botanics Holdings had a market capitalisation of AU$15.55m.
Here are the trading details for ECS Botanics Holdings:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: ECS
Based on an overall assessment of its quality, value and momentum ECS Botanics Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ECS Botanics Holdings. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -22.85%.
As of the last closing price of AU$0.01, shares in ECS Botanics Holdings were trading -23.64% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ECS Botanics Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
ECS Botanics Holdings' management team is headed by:
- Robert Pickering - CTO
- Damian Woods - OTH
- Mauro Piccini - SEC
- Alexander Keach - DRC
- Jeremy King - DRC
- David McCredie - DRC
- Nan - Maree Schoerie - DRC
- Michael Nitsche - NED